This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106b-5p | AKT3 | 2.81 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.41 | 1.0E-5 | NA | |
2 | hsa-miR-142-3p | AKT3 | 4.35 | 0 | -3.33 | 1.0E-5 | miRanda | -0.16 | 0.00934 | NA | |
3 | hsa-miR-15a-5p | AKT3 | 2.05 | 0 | -3.33 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.37 | 0.00021 | NA | |
4 | hsa-miR-15b-5p | AKT3 | 3.32 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.25 | 0.00571 | NA | |
5 | hsa-miR-16-5p | AKT3 | 2.94 | 0 | -3.33 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 0.00086 | NA | |
6 | hsa-miR-29b-3p | AKT3 | 0.67 | 0.23406 | -3.33 | 1.0E-5 | miRNATAP | -0.28 | 0.00031 | 26512921 | MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 |
7 | hsa-miR-3065-5p | AKT3 | 2.14 | 0.06094 | -3.33 | 1.0E-5 | mirMAP | -0.22 | 0 | NA | |
8 | hsa-miR-362-3p | AKT3 | 0.68 | 0.22615 | -3.33 | 1.0E-5 | miRanda | -0.25 | 0.00124 | NA | |
9 | hsa-miR-501-3p | AKT3 | 1.72 | 0.00759 | -3.33 | 1.0E-5 | miRNATAP | -0.18 | 0.00733 | NA | |
10 | hsa-miR-93-5p | AKT3 | 2.66 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.33 | 0.00021 | NA | |
11 | hsa-miR-146b-5p | BRAF | 1.88 | 0.00074 | 0.87 | 0.02116 | miRanda | -0.1 | 0.0087 | 21874046; 26883911; 20406109; 21537871 | Additionally the activation of thyroid most common oncogenes RET/PTC3 and BRAF in PCCL3 cells upregulated miR-146b-5p expression;miR-146b-5p positively regulates migration and invasion of thyroid normal and tumor follicular cells independently from their original mutation either BRAF or RET/PTC through a mechanism that involves the actin cytoskeleton but not an increased capacity of matrix degradation;The miR-146b expression levels in PTCs with BRAF mutation were significantly higher than those without this mutation p < 0.0001;Among BRAF-positive tumors overexpression of miR-146b was associated with aggressive behavior suggesting that it may further refine the prognostic importance of BRAF |
12 | hsa-miR-200b-3p | CAB39 | 5.56 | 0 | -0.04 | 0.90683 | MirTarget; TargetScan | -0.1 | 0.00021 | NA | |
13 | hsa-miR-155-5p | CAB39L | 2.81 | 7.0E-5 | -2.97 | 0 | miRNAWalker2 validate | -0.24 | 0 | NA | |
14 | hsa-miR-33a-3p | CAB39L | 2.06 | 0.00156 | -2.97 | 0 | MirTarget | -0.18 | 0.00143 | NA | |
15 | hsa-miR-342-3p | CAB39L | 1.31 | 0.02072 | -2.97 | 0 | miRanda | -0.29 | 0 | NA | |
16 | hsa-miR-590-3p | CAB39L | 2.35 | 0 | -2.97 | 0 | miRanda | -0.31 | 2.0E-5 | NA | |
17 | hsa-miR-590-5p | CAB39L | 1.51 | 0.00239 | -2.97 | 0 | miRanda | -0.25 | 0.00067 | NA | |
18 | hsa-miR-101-3p | DDIT4 | -1.12 | 0.02009 | 0.48 | 0.49995 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.23 | 0.00577 | NA | |
19 | hsa-miR-200b-3p | DDIT4 | 5.56 | 0 | 0.48 | 0.49995 | TargetScan | -0.15 | 0.00841 | NA | |
20 | hsa-miR-30c-5p | EIF4E | 0.39 | 0.34861 | -0.04 | 0.91192 | mirMAP | -0.13 | 0.00522 | NA | |
21 | hsa-miR-125a-5p | EIF4EBP1 | -1.32 | 0.00714 | 1.78 | 0.00058 | miRNAWalker2 validate; MirTarget; miRanda; miRNATAP | -0.19 | 0.00177 | 26646586 | Increased expression of miR-125a and miR-125b inhibited invasion and migration of SKOV3 and OVCAR-429 ovarian cancer cells and was associated with a decrease in EIF4EBP1 expression |
22 | hsa-miR-28-5p | HIF1A | -0.82 | 0.02212 | 0.73 | 0.1694 | miRanda | -0.25 | 0.00323 | NA | |
23 | hsa-let-7f-1-3p | IGF1 | 1.62 | 0.00069 | -4.48 | 0.00149 | mirMAP | -0.92 | 0 | NA | |
24 | hsa-miR-103a-2-5p | IGF1 | 2.77 | 0.0003 | -4.48 | 0.00149 | mirMAP | -0.61 | 0 | NA | |
25 | hsa-miR-130b-3p | IGF1 | 3.92 | 0 | -4.48 | 0.00149 | MirTarget | -0.48 | 0.00036 | NA | |
26 | hsa-miR-15b-3p | IGF1 | 3.58 | 0 | -4.48 | 0.00149 | mirMAP | -0.73 | 0 | NA | |
27 | hsa-miR-16-1-3p | IGF1 | 2.83 | 0 | -4.48 | 0.00149 | mirMAP | -0.81 | 0 | NA | |
28 | hsa-miR-19a-3p | IGF1 | 2.17 | 0.00122 | -4.48 | 0.00149 | MirTarget | -0.58 | 0 | NA | |
29 | hsa-miR-19b-1-5p | IGF1 | 1.51 | 0.00147 | -4.48 | 0.00149 | mirMAP | -1.02 | 0 | NA | |
30 | hsa-miR-19b-3p | IGF1 | 1.68 | 0.00086 | -4.48 | 0.00149 | MirTarget | -0.83 | 0 | NA | |
31 | hsa-miR-20a-3p | IGF1 | 1.99 | 0.00062 | -4.48 | 0.00149 | mirMAP | -0.77 | 0 | NA | |
32 | hsa-miR-27a-3p | IGF1 | 1.76 | 0.00022 | -4.48 | 0.00149 | miRNAWalker2 validate; miRTarBase | -1.1 | 0 | NA | |
33 | hsa-miR-301a-3p | IGF1 | 1.99 | 0.00081 | -4.48 | 0.00149 | MirTarget | -0.46 | 0.00055 | NA | |
34 | hsa-miR-32-3p | IGF1 | 2.2 | 0.03928 | -4.48 | 0.00149 | mirMAP | -0.55 | 3.0E-5 | NA | |
35 | hsa-miR-33a-3p | IGF1 | 2.06 | 0.00156 | -4.48 | 0.00149 | MirTarget | -0.4 | 0.00118 | NA | |
36 | hsa-miR-452-5p | IGF1 | 2.45 | 0.00115 | -4.48 | 0.00149 | MirTarget; mirMAP | -0.29 | 0.00626 | NA | |
37 | hsa-miR-486-5p | IGF1 | 1.11 | 0.30929 | -4.48 | 0.00149 | PITA; miRNATAP | -0.35 | 0 | NA | |
38 | hsa-miR-576-5p | IGF1 | 1.3 | 0.00649 | -4.48 | 0.00149 | PITA; mirMAP; miRNATAP | -0.69 | 4.0E-5 | NA | |
39 | hsa-miR-629-5p | IGF1 | 1.57 | 0.01157 | -4.48 | 0.00149 | mirMAP | -0.43 | 0.0009 | NA | |
40 | hsa-miR-940 | IGF1 | 3.78 | 5.0E-5 | -4.48 | 0.00149 | MirTarget; PITA; miRNATAP | -0.34 | 0.00113 | NA | |
41 | hsa-miR-148b-3p | MAPK1 | 1.76 | 0 | 0.01 | 0.9644 | mirMAP | -0.14 | 0.00442 | NA | |
42 | hsa-miR-29b-2-5p | MAPK1 | -0.6 | 0.18954 | 0.01 | 0.9644 | mirMAP | -0.15 | 2.0E-5 | NA | |
43 | hsa-miR-29c-3p | MAPK1 | -0.41 | 0.52934 | 0.01 | 0.9644 | mirMAP | -0.12 | 0 | NA | |
44 | hsa-miR-30b-5p | MAPK1 | 0.02 | 0.95322 | 0.01 | 0.9644 | mirMAP | -0.11 | 0.00754 | NA | |
45 | hsa-miR-30e-5p | MAPK1 | 0.78 | 0.03467 | 0.01 | 0.9644 | mirMAP | -0.12 | 0.00886 | NA | |
46 | hsa-miR-3913-5p | MAPK1 | 0.15 | 0.73484 | 0.01 | 0.9644 | mirMAP | -0.11 | 0.0044 | NA | |
47 | hsa-miR-2355-5p | PDPK1 | 0.42 | 0.50215 | 0.31 | 0.47594 | mirMAP | -0.1 | 0.00842 | NA | |
48 | hsa-miR-331-3p | PDPK1 | 2.61 | 0 | 0.31 | 0.47594 | miRNAWalker2 validate | -0.12 | 0.00928 | NA | |
49 | hsa-miR-335-5p | PDPK1 | 0.17 | 0.8039 | 0.31 | 0.47594 | mirMAP | -0.12 | 0.0009 | NA | |
50 | hsa-miR-374a-3p | PDPK1 | 0.47 | 0.30527 | 0.31 | 0.47594 | mirMAP | -0.23 | 2.0E-5 | NA | |
51 | hsa-miR-374b-5p | PDPK1 | -0.11 | 0.76489 | 0.31 | 0.47594 | miRNATAP | -0.2 | 0.00228 | NA | |
52 | hsa-miR-424-5p | PDPK1 | 0.21 | 0.75371 | 0.31 | 0.47594 | mirMAP | -0.11 | 0.00322 | NA | |
53 | hsa-miR-505-3p | PDPK1 | 0.59 | 0.22694 | 0.31 | 0.47594 | mirMAP | -0.16 | 0.00135 | NA | |
54 | hsa-miR-590-3p | PDPK1 | 2.35 | 0 | 0.31 | 0.47594 | miRanda; miRNATAP | -0.15 | 0.00127 | NA | |
55 | hsa-miR-7-1-3p | PDPK1 | 1.43 | 0.00471 | 0.31 | 0.47594 | mirMAP | -0.17 | 0.00048 | NA | |
56 | hsa-miR-708-3p | PDPK1 | 0.78 | 0.29065 | 0.31 | 0.47594 | miRNATAP | -0.1 | 0.00176 | NA | |
57 | hsa-miR-34a-5p | PGF | 0.83 | 0.04775 | 0.03 | 0.97889 | miRNATAP | -0.47 | 0.00035 | NA | |
58 | hsa-miR-429 | PGF | 6.4 | 0 | 0.03 | 0.97889 | miRNATAP | -0.26 | 0.0002 | NA | |
59 | hsa-miR-148b-3p | PIK3CA | 1.76 | 0 | 0.51 | 0.24893 | miRNAWalker2 validate | -0.24 | 0.00148 | NA | |
60 | hsa-miR-186-5p | PIK3CA | 0.45 | 0.18545 | 0.51 | 0.24893 | mirMAP | -0.28 | 0.00023 | NA | |
61 | hsa-miR-29b-1-5p | PIK3CA | 0.34 | 0.59809 | 0.51 | 0.24893 | mirMAP | -0.12 | 0.00234 | NA | |
62 | hsa-miR-320b | PIK3CA | 0.2 | 0.72722 | 0.51 | 0.24893 | miRanda | -0.12 | 0.00551 | NA | |
63 | hsa-miR-335-5p | PIK3CA | 0.17 | 0.8039 | 0.51 | 0.24893 | miRNAWalker2 validate | -0.12 | 0.00088 | NA | |
64 | hsa-miR-338-5p | PIK3CA | -0.11 | 0.89468 | 0.51 | 0.24893 | mirMAP | -0.11 | 0.00047 | NA | |
65 | hsa-miR-339-5p | PIK3CA | 1.23 | 0.03075 | 0.51 | 0.24893 | miRanda | -0.14 | 0.00178 | NA | |
66 | hsa-miR-501-5p | PIK3CA | 1.04 | 0.07772 | 0.51 | 0.24893 | mirMAP | -0.12 | 0.00474 | NA | |
67 | hsa-miR-130a-3p | PIK3CB | 0.18 | 0.75775 | 0.9 | 0.01258 | miRNATAP | -0.12 | 0.00106 | NA | |
68 | hsa-miR-19b-3p | PIK3CB | 1.68 | 0.00086 | 0.9 | 0.01258 | miRNATAP | -0.11 | 0.00639 | NA | |
69 | hsa-miR-1468-5p | PIK3CD | -1.63 | 0.00779 | 0.06 | 0.92656 | MirTarget | -0.15 | 0.0056 | NA | |
70 | hsa-miR-199a-5p | PIK3CD | -1.25 | 0.07478 | 0.06 | 0.92656 | MirTarget; PITA; miRanda; miRNATAP | -0.16 | 0.00086 | NA | |
71 | hsa-miR-30d-5p | PIK3CD | 0.3 | 0.38019 | 0.06 | 0.92656 | MirTarget; miRNATAP | -0.27 | 0.00723 | NA | |
72 | hsa-miR-3913-5p | PIK3CD | 0.15 | 0.73484 | 0.06 | 0.92656 | mirMAP | -0.26 | 0.00117 | NA | |
73 | hsa-miR-335-3p | PIK3CG | 1.2 | 0.09389 | -0.16 | 0.84867 | mirMAP | -0.29 | 1.0E-5 | NA | |
74 | hsa-miR-16-2-3p | PIK3R1 | 3.8 | 0 | -1.85 | 0.01274 | MirTarget | -0.22 | 0.0055 | NA | |
75 | hsa-miR-16-5p | PIK3R1 | 2.94 | 0 | -1.85 | 0.01274 | MirTarget | -0.23 | 0.00941 | NA | |
76 | hsa-miR-17-5p | PIK3R1 | 2.33 | 2.0E-5 | -1.85 | 0.01274 | MirTarget; TargetScan; miRNATAP | -0.26 | 0.00056 | NA | |
77 | hsa-miR-200c-3p | PIK3R1 | 6.47 | 0 | -1.85 | 0.01274 | mirMAP | -0.21 | 0.00097 | NA | |
78 | hsa-miR-29b-3p | PIK3R1 | 0.67 | 0.23406 | -1.85 | 0.01274 | MirTarget; miRNATAP | -0.23 | 0.00248 | NA | |
79 | hsa-miR-3065-5p | PIK3R1 | 2.14 | 0.06094 | -1.85 | 0.01274 | MirTarget; mirMAP; miRNATAP | -0.14 | 0.003 | NA | |
80 | hsa-miR-320c | PIK3R1 | -0.11 | 0.854 | -1.85 | 0.01274 | miRNATAP | -0.24 | 0.00153 | NA | |
81 | hsa-miR-330-3p | PIK3R1 | 2.49 | 0.00013 | -1.85 | 0.01274 | MirTarget; PITA; miRNATAP | -0.22 | 0.00056 | NA | |
82 | hsa-miR-335-3p | PIK3R1 | 1.2 | 0.09389 | -1.85 | 0.01274 | mirMAP | -0.19 | 0.00155 | NA | |
83 | hsa-miR-338-5p | PIK3R1 | -0.11 | 0.89468 | -1.85 | 0.01274 | PITA | -0.15 | 0.00415 | NA | |
84 | hsa-miR-582-5p | PIK3R1 | 0.69 | 0.44776 | -1.85 | 0.01274 | mirMAP | -0.17 | 0.00029 | NA | |
85 | hsa-miR-584-5p | PIK3R1 | 1.18 | 0.20286 | -1.85 | 0.01274 | mirMAP | -0.26 | 0 | NA | |
86 | hsa-miR-590-5p | PIK3R1 | 1.51 | 0.00239 | -1.85 | 0.01274 | MirTarget; PITA; miRanda; miRNATAP | -0.3 | 0.00045 | NA | |
87 | hsa-miR-629-3p | PIK3R1 | 3.48 | 0 | -1.85 | 0.01274 | MirTarget | -0.21 | 0.00106 | NA | |
88 | hsa-miR-1271-5p | PIK3R3 | 0.21 | 0.74254 | -0.03 | 0.95933 | mirMAP | -0.15 | 0.003 | NA | |
89 | hsa-miR-18a-3p | PIK3R3 | 3.65 | 0 | -0.03 | 0.95933 | miRNAWalker2 validate | -0.17 | 9.0E-5 | NA | |
90 | hsa-miR-222-5p | PIK3R3 | 2.52 | 0.00142 | -0.03 | 0.95933 | mirMAP | -0.17 | 4.0E-5 | NA | |
91 | hsa-miR-29b-1-5p | PIK3R3 | 0.34 | 0.59809 | -0.03 | 0.95933 | mirMAP | -0.21 | 3.0E-5 | NA | |
92 | hsa-miR-330-3p | PIK3R3 | 2.49 | 0.00013 | -0.03 | 0.95933 | MirTarget | -0.19 | 0.00014 | NA | |
93 | hsa-miR-330-5p | PIK3R3 | 2.25 | 0.00028 | -0.03 | 0.95933 | miRanda | -0.16 | 0.00263 | NA | |
94 | hsa-miR-365a-3p | PIK3R3 | 0.26 | 0.65432 | -0.03 | 0.95933 | MirTarget | -0.33 | 0 | NA | |
95 | hsa-miR-511-5p | PIK3R3 | 1.1 | 0.17928 | -0.03 | 0.95933 | MirTarget | -0.18 | 1.0E-5 | 25608840 | MiR 511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3; We further demonstrated that miR-511 suppressed HCC cell proliferation migration and invasion by repressing PIK3R3 expression |
96 | hsa-miR-590-5p | PIK3R3 | 1.51 | 0.00239 | -0.03 | 0.95933 | miRanda | -0.2 | 0.00312 | NA | |
97 | hsa-miR-125a-3p | PIK3R5 | -0.07 | 0.92074 | 0.76 | 0.28692 | miRanda | -0.14 | 0.00747 | NA | |
98 | hsa-miR-125a-5p | PIK3R5 | -1.32 | 0.00714 | 0.76 | 0.28692 | MirTarget; miRanda | -0.25 | 0.00223 | NA | |
99 | hsa-miR-182-5p | PIK3R5 | 5.87 | 0 | 0.76 | 0.28692 | MirTarget | -0.25 | 0 | NA | |
100 | hsa-miR-19a-3p | PRKAA1 | 2.17 | 0.00122 | -0.14 | 0.70846 | miRNATAP | -0.12 | 0.00012 | NA | |
101 | hsa-miR-19b-3p | PRKAA1 | 1.68 | 0.00086 | -0.14 | 0.70846 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.14 | 0.00076 | NA | |
102 | hsa-miR-590-3p | PRKAA1 | 2.35 | 0 | -0.14 | 0.70846 | MirTarget; miRanda; mirMAP | -0.16 | 0.00015 | NA | |
103 | hsa-miR-590-5p | PRKAA1 | 1.51 | 0.00239 | -0.14 | 0.70846 | miRanda | -0.13 | 0.00313 | NA | |
104 | hsa-miR-142-5p | PRKAA2 | 3.96 | 0 | -1.64 | 0.30459 | mirMAP | -0.73 | 0 | NA | |
105 | hsa-miR-146a-5p | PRKAA2 | 2.65 | 0.00028 | -1.64 | 0.30459 | MirTarget | -0.51 | 3.0E-5 | NA | |
106 | hsa-miR-146b-5p | PRKAA2 | 1.88 | 0.00074 | -1.64 | 0.30459 | MirTarget | -0.68 | 3.0E-5 | NA | |
107 | hsa-miR-150-3p | PRKAA2 | 1.65 | 0.05848 | -1.64 | 0.30459 | MirTarget; miRNATAP | -0.56 | 0 | NA | |
108 | hsa-miR-203a-3p | PRKAA2 | 6.35 | 0 | -1.64 | 0.30459 | MirTarget | -0.43 | 0 | NA | |
109 | hsa-miR-22-5p | PRKAA2 | 2.38 | 1.0E-5 | -1.64 | 0.30459 | mirMAP | -0.47 | 0.00457 | NA | |
110 | hsa-miR-23a-3p | PRKAA2 | 0.93 | 0.01273 | -1.64 | 0.30459 | mirMAP | -0.71 | 0.00406 | NA | |
111 | hsa-miR-27b-5p | PRKAA2 | 0.21 | 0.71562 | -1.64 | 0.30459 | MirTarget; miRNATAP | -0.61 | 8.0E-5 | NA | |
112 | hsa-miR-342-3p | PRKAA2 | 1.31 | 0.02072 | -1.64 | 0.30459 | PITA | -1.03 | 0 | NA | |
113 | hsa-miR-34c-3p | PRKAA2 | 4.04 | 0.0002 | -1.64 | 0.30459 | PITA | -0.35 | 2.0E-5 | NA | |
114 | hsa-miR-34c-5p | PRKAA2 | 2.65 | 0.01574 | -1.64 | 0.30459 | miRNATAP | -0.35 | 2.0E-5 | NA | |
115 | hsa-miR-590-3p | PRKAA2 | 2.35 | 0 | -1.64 | 0.30459 | mirMAP; miRNATAP | -0.48 | 0.00777 | NA | |
116 | hsa-miR-944 | PRKAA2 | 7.21 | 0.00082 | -1.64 | 0.30459 | mirMAP | -0.38 | 0 | NA | |
117 | hsa-miR-15b-3p | RICTOR | 3.58 | 0 | -0.25 | 0.52233 | mirMAP | -0.12 | 0.00225 | NA | |
118 | hsa-miR-16-1-3p | RICTOR | 2.83 | 0 | -0.25 | 0.52233 | MirTarget | -0.14 | 0.00111 | NA | |
119 | hsa-miR-188-5p | RICTOR | 1.39 | 0.02516 | -0.25 | 0.52233 | MirTarget; PITA; miRNATAP | -0.11 | 0.00114 | NA | |
120 | hsa-miR-26b-3p | RICTOR | 0.99 | 0.03514 | -0.25 | 0.52233 | MirTarget | -0.14 | 0.00252 | NA | |
121 | hsa-miR-590-3p | RICTOR | 2.35 | 0 | -0.25 | 0.52233 | MirTarget; PITA; miRanda; mirMAP; miRNATAP | -0.12 | 0.00543 | NA | |
122 | hsa-miR-660-5p | RICTOR | -0.07 | 0.88525 | -0.25 | 0.52233 | MirTarget | -0.2 | 2.0E-5 | NA | |
123 | hsa-miR-1271-5p | RPS6KA2 | 0.21 | 0.74254 | -2.65 | 0.0006 | mirMAP | -0.21 | 0.00269 | NA | |
124 | hsa-miR-17-5p | RPS6KA2 | 2.33 | 2.0E-5 | -2.65 | 0.0006 | TargetScan | -0.28 | 0.00049 | NA | |
125 | hsa-miR-193a-3p | RPS6KA2 | 0.65 | 0.20713 | -2.65 | 0.0006 | mirMAP | -0.24 | 0.00506 | NA | |
126 | hsa-miR-19b-3p | RPS6KA2 | 1.68 | 0.00086 | -2.65 | 0.0006 | MirTarget | -0.28 | 0.00168 | NA | |
127 | hsa-miR-200c-3p | RPS6KA2 | 6.47 | 0 | -2.65 | 0.0006 | miRNATAP | -0.19 | 0.00537 | NA | |
128 | hsa-miR-30e-5p | RPS6KA2 | 0.78 | 0.03467 | -2.65 | 0.0006 | MirTarget | -0.49 | 5.0E-5 | NA | |
129 | hsa-miR-378a-3p | RPS6KA2 | 1.47 | 0.04667 | -2.65 | 0.0006 | MirTarget | -0.25 | 2.0E-5 | NA | |
130 | hsa-miR-378c | RPS6KA2 | 0.45 | 0.49938 | -2.65 | 0.0006 | MirTarget | -0.19 | 0.00355 | NA | |
131 | hsa-miR-9-3p | RPS6KA2 | 1.69 | 0.12517 | -2.65 | 0.0006 | MirTarget | -0.17 | 2.0E-5 | NA | |
132 | hsa-miR-9-5p | RPS6KA2 | 1.8 | 0.14527 | -2.65 | 0.0006 | miRNATAP | -0.18 | 0 | NA | |
133 | hsa-miR-141-3p | RPS6KA6 | 7.3 | 0 | -4.02 | 0.00361 | MirTarget | -0.31 | 0.00251 | NA | |
134 | hsa-miR-15b-5p | RPS6KA6 | 3.32 | 0 | -4.02 | 0.00361 | MirTarget | -0.63 | 0.00011 | NA | |
135 | hsa-miR-16-5p | RPS6KA6 | 2.94 | 0 | -4.02 | 0.00361 | MirTarget | -0.76 | 0 | NA | |
136 | hsa-miR-17-5p | RPS6KA6 | 2.33 | 2.0E-5 | -4.02 | 0.00361 | TargetScan | -0.43 | 0.00258 | NA | |
137 | hsa-miR-19b-3p | RPS6KA6 | 1.68 | 0.00086 | -4.02 | 0.00361 | MirTarget | -0.41 | 0.00915 | NA | |
138 | hsa-miR-20a-3p | RPS6KA6 | 1.99 | 0.00062 | -4.02 | 0.00361 | MirTarget | -0.37 | 0.00636 | NA | |
139 | hsa-miR-107 | RPS6KB1 | 1.49 | 0.00013 | 0.15 | 0.60051 | PITA; miRanda | -0.11 | 0.00609 | NA | |
140 | hsa-miR-186-5p | RPS6KB1 | 0.45 | 0.18545 | 0.15 | 0.60051 | MirTarget; miRNATAP | -0.19 | 8.0E-5 | NA | |
141 | hsa-miR-125a-5p | RPS6KB2 | -1.32 | 0.00714 | 0.88 | 0.01183 | miRanda | -0.17 | 2.0E-5 | NA | |
142 | hsa-miR-330-3p | STK11 | 2.49 | 0.00013 | -0.26 | 0.64146 | mirMAP | -0.18 | 0.0002 | NA | |
143 | hsa-miR-330-5p | STK11 | 2.25 | 0.00028 | -0.26 | 0.64146 | miRanda | -0.23 | 1.0E-5 | NA | |
144 | hsa-miR-186-5p | STRADA | 0.45 | 0.18545 | -0.23 | 0.39724 | mirMAP | -0.12 | 0.00877 | NA | |
145 | hsa-miR-28-3p | TSC1 | -0.99 | 0.01882 | -0.16 | 0.55846 | PITA | -0.16 | 1.0E-5 | NA | |
146 | hsa-miR-29a-5p | TSC1 | 0.07 | 0.88413 | -0.16 | 0.55846 | mirMAP | -0.11 | 0.00063 | NA | |
147 | hsa-miR-320b | ULK1 | 0.2 | 0.72722 | -0.27 | 0.44303 | miRNATAP | -0.11 | 0.00133 | NA | |
148 | hsa-miR-338-5p | ULK1 | -0.11 | 0.89468 | -0.27 | 0.44303 | PITA | -0.11 | 0 | NA | |
149 | hsa-miR-92b-3p | ULK1 | 1.69 | 0.01035 | -0.27 | 0.44303 | miRNATAP | -0.11 | 0.00011 | NA | |
150 | hsa-let-7f-1-3p | ULK2 | 1.62 | 0.00069 | -0.93 | 0.02765 | MirTarget | -0.17 | 0.00078 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PHOSPHORYLATION | 23 | 1228 | 5.64e-21 | 2.624e-17 |
2 | PROTEIN PHOSPHORYLATION | 21 | 944 | 2.372e-20 | 5.518e-17 |
3 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 24 | 1977 | 1.061e-17 | 1.646e-14 |
4 | INTRACELLULAR SIGNAL TRANSDUCTION | 22 | 1572 | 3.621e-17 | 4.212e-14 |
5 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 22 | 1618 | 6.681e-17 | 6.217e-14 |
6 | INOSITOL LIPID MEDIATED SIGNALING | 10 | 124 | 4.76e-15 | 3.691e-12 |
7 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 17 | 1036 | 6.51e-14 | 3.786e-11 |
8 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 17 | 1036 | 6.51e-14 | 3.786e-11 |
9 | REGULATION OF KINASE ACTIVITY | 15 | 776 | 3.218e-13 | 1.664e-10 |
10 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 19 | 1656 | 6.643e-13 | 3.091e-10 |
11 | PEPTIDYL SERINE MODIFICATION | 9 | 148 | 1.726e-12 | 7.299e-10 |
12 | PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 6 | 25 | 2.16e-12 | 8.376e-10 |
13 | REGULATION OF TRANSFERASE ACTIVITY | 15 | 946 | 5.545e-12 | 1.985e-09 |
14 | POSITIVE REGULATION OF KINASE ACTIVITY | 12 | 482 | 7.512e-12 | 2.33e-09 |
15 | NEGATIVE REGULATION OF TOR SIGNALING | 6 | 30 | 7.201e-12 | 2.33e-09 |
16 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 19 | 1929 | 1.005e-11 | 2.922e-09 |
17 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 12 | 498 | 1.099e-11 | 3.008e-09 |
18 | REGULATION OF TOR SIGNALING | 7 | 68 | 1.523e-11 | 3.856e-09 |
19 | REGULATION OF PROTEIN MODIFICATION PROCESS | 18 | 1710 | 1.628e-11 | 3.856e-09 |
20 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 10 | 279 | 1.657e-11 | 3.856e-09 |
21 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 17 | 1492 | 2.32e-11 | 5.14e-09 |
22 | RESPONSE TO PEPTIDE | 11 | 404 | 2.592e-11 | 5.481e-09 |
23 | RESPONSE TO INSULIN | 9 | 205 | 3.265e-11 | 6.605e-09 |
24 | CELLULAR RESPONSE TO HORMONE STIMULUS | 12 | 552 | 3.631e-11 | 7.039e-09 |
25 | RESPONSE TO HORMONE | 14 | 893 | 4.196e-11 | 7.809e-09 |
26 | CELL ACTIVATION | 12 | 568 | 5.052e-11 | 9.042e-09 |
27 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 15 | 1135 | 7.345e-11 | 1.266e-08 |
28 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 12 | 616 | 1.287e-10 | 2.139e-08 |
29 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 6 | 49 | 1.659e-10 | 2.662e-08 |
30 | RESPONSE TO ABIOTIC STIMULUS | 14 | 1024 | 2.56e-10 | 3.97e-08 |
31 | RESPONSE TO NITROGEN COMPOUND | 13 | 859 | 3.992e-10 | 5.991e-08 |
32 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 12 | 689 | 4.641e-10 | 6.748e-08 |
33 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 289 | 6.904e-10 | 9.734e-08 |
34 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 7 | 120 | 8.806e-10 | 1.205e-07 |
35 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 15 | 1381 | 1.137e-09 | 1.512e-07 |
36 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 74 | 2.135e-09 | 2.759e-07 |
37 | RESPONSE TO ENDOGENOUS STIMULUS | 15 | 1450 | 2.229e-09 | 2.803e-07 |
38 | POSITIVE REGULATION OF AUTOPHAGY | 6 | 75 | 2.318e-09 | 2.838e-07 |
39 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 12 | 799 | 2.492e-09 | 2.973e-07 |
40 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 10 | 470 | 2.663e-09 | 3.098e-07 |
41 | PLATELET ACTIVATION | 7 | 142 | 2.869e-09 | 3.105e-07 |
42 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 13 | 1008 | 2.803e-09 | 3.105e-07 |
43 | REGULATION OF CELL ADHESION | 11 | 629 | 2.814e-09 | 3.105e-07 |
44 | REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 5 | 36 | 3.238e-09 | 3.424e-07 |
45 | CELLULAR RESPONSE TO INSULIN STIMULUS | 7 | 146 | 3.484e-09 | 3.524e-07 |
46 | T CELL RECEPTOR SIGNALING PATHWAY | 7 | 146 | 3.484e-09 | 3.524e-07 |
47 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 15 | 1518 | 4.182e-09 | 4.14e-07 |
48 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 16 | 1791 | 4.271e-09 | 4.14e-07 |
49 | CELL CYCLE ARREST | 7 | 154 | 5.054e-09 | 4.799e-07 |
50 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 10 | 505 | 5.297e-09 | 4.929e-07 |
51 | REGULATION OF AUTOPHAGY | 8 | 249 | 5.474e-09 | 4.994e-07 |
52 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 12 | 867 | 6.244e-09 | 5.587e-07 |
53 | REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 6 | 89 | 6.581e-09 | 5.778e-07 |
54 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 16 | 1848 | 6.723e-09 | 5.793e-07 |
55 | POSITIVE REGULATION OF CELL ADHESION | 9 | 376 | 6.904e-09 | 5.841e-07 |
56 | REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS | 5 | 42 | 7.254e-09 | 5.922e-07 |
57 | REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 5 | 42 | 7.254e-09 | 5.922e-07 |
58 | CELLULAR RESPONSE TO PEPTIDE | 8 | 274 | 1.156e-08 | 9.277e-07 |
59 | LIPID PHOSPHORYLATION | 6 | 99 | 1.254e-08 | 9.893e-07 |
60 | REGULATION OF CATABOLIC PROCESS | 11 | 731 | 1.339e-08 | 1.038e-06 |
61 | POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 4 | 17 | 1.439e-08 | 1.098e-06 |
62 | RESPONSE TO WOUNDING | 10 | 563 | 1.491e-08 | 1.119e-06 |
63 | REGULATION OF NUCLEOSIDE METABOLIC PROCESS | 5 | 49 | 1.613e-08 | 1.173e-06 |
64 | REGULATION OF ATP METABOLIC PROCESS | 5 | 49 | 1.613e-08 | 1.173e-06 |
65 | REGULATION OF CELL CYCLE | 12 | 949 | 1.712e-08 | 1.225e-06 |
66 | REGULATION OF COENZYME METABOLIC PROCESS | 5 | 50 | 1.79e-08 | 1.243e-06 |
67 | REGULATION OF COFACTOR METABOLIC PROCESS | 5 | 50 | 1.79e-08 | 1.243e-06 |
68 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 7 | 193 | 2.414e-08 | 1.652e-06 |
69 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 7 | 195 | 2.592e-08 | 1.748e-06 |
70 | REGULATION OF CELL DEATH | 14 | 1472 | 2.781e-08 | 1.849e-06 |
71 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 11 | 788 | 2.898e-08 | 1.873e-06 |
72 | CIRCULATORY SYSTEM DEVELOPMENT | 11 | 788 | 2.898e-08 | 1.873e-06 |
73 | RESPONSE TO OXYGEN LEVELS | 8 | 311 | 3.094e-08 | 1.972e-06 |
74 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 6 | 118 | 3.609e-08 | 2.269e-06 |
75 | REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 5 | 59 | 4.185e-08 | 2.597e-06 |
76 | LIPID MODIFICATION | 7 | 210 | 4.314e-08 | 2.641e-06 |
77 | REGULATION OF GLUCOSE IMPORT | 5 | 60 | 4.561e-08 | 2.676e-06 |
78 | POSITIVE REGULATION OF CELL COMMUNICATION | 14 | 1532 | 4.608e-08 | 2.676e-06 |
79 | GLYCEROLIPID BIOSYNTHETIC PROCESS | 7 | 211 | 4.457e-08 | 2.676e-06 |
80 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 13 | 1275 | 4.658e-08 | 2.676e-06 |
81 | VASCULATURE DEVELOPMENT | 9 | 469 | 4.646e-08 | 2.676e-06 |
82 | WOUND HEALING | 9 | 470 | 4.731e-08 | 2.685e-06 |
83 | RESPONSE TO EXTERNAL STIMULUS | 15 | 1821 | 4.923e-08 | 2.76e-06 |
84 | CELL MOTILITY | 11 | 835 | 5.24e-08 | 2.869e-06 |
85 | LOCALIZATION OF CELL | 11 | 835 | 5.24e-08 | 2.869e-06 |
86 | POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS | 4 | 24 | 6.374e-08 | 3.409e-06 |
87 | POSITIVE REGULATION OF ATP METABOLIC PROCESS | 4 | 24 | 6.374e-08 | 3.409e-06 |
88 | NEGATIVE REGULATION OF CELL DEATH | 11 | 872 | 8.146e-08 | 4.307e-06 |
89 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 8 | 354 | 8.4e-08 | 4.392e-06 |
90 | REGULATION OF BODY FLUID LEVELS | 9 | 506 | 8.885e-08 | 4.594e-06 |
91 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 6 | 138 | 9.193e-08 | 4.701e-06 |
92 | PHOSPHOLIPID BIOSYNTHETIC PROCESS | 7 | 235 | 9.314e-08 | 4.71e-06 |
93 | LOCOMOTION | 12 | 1114 | 1.002e-07 | 5.014e-06 |
94 | LIPID BIOSYNTHETIC PROCESS | 9 | 539 | 1.52e-07 | 7.523e-06 |
95 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 6 | 154 | 1.763e-07 | 8.636e-06 |
96 | PROTEIN KINASE B SIGNALING | 4 | 34 | 2.75e-07 | 1.333e-05 |
97 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 10 | 771 | 2.828e-07 | 1.356e-05 |
98 | REGULATION OF CELL PROLIFERATION | 13 | 1496 | 3.021e-07 | 1.434e-05 |
99 | POSITIVE REGULATION OF LOCOMOTION | 8 | 420 | 3.101e-07 | 1.456e-05 |
100 | GLUCOSE HOMEOSTASIS | 6 | 170 | 3.161e-07 | 1.456e-05 |
101 | CARBOHYDRATE HOMEOSTASIS | 6 | 170 | 3.161e-07 | 1.456e-05 |
102 | REGULATION OF LIPID METABOLIC PROCESS | 7 | 282 | 3.21e-07 | 1.465e-05 |
103 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 7 | 285 | 3.448e-07 | 1.556e-05 |
104 | REGULATION OF CELL SUBSTRATE ADHESION | 6 | 173 | 3.504e-07 | 1.556e-05 |
105 | REGULATION OF CELL MATRIX ADHESION | 5 | 90 | 3.544e-07 | 1.556e-05 |
106 | REGULATION OF TRANSPORT | 14 | 1804 | 3.535e-07 | 1.556e-05 |
107 | NEGATIVE REGULATION OF CELL CYCLE | 8 | 433 | 3.908e-07 | 1.699e-05 |
108 | ANGIOGENESIS | 7 | 293 | 4.156e-07 | 1.79e-05 |
109 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 7 | 296 | 4.451e-07 | 1.9e-05 |
110 | GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 7 | 297 | 4.553e-07 | 1.926e-05 |
111 | CELLULAR RESPONSE TO STRESS | 13 | 1565 | 5.081e-07 | 2.13e-05 |
112 | REGULATION OF GLUCOSE TRANSPORT | 5 | 100 | 6e-07 | 2.493e-05 |
113 | HEMOSTASIS | 7 | 311 | 6.205e-07 | 2.555e-05 |
114 | POSITIVE REGULATION OF MAPK CASCADE | 8 | 470 | 7.26e-07 | 2.963e-05 |
115 | REGULATION OF MAP KINASE ACTIVITY | 7 | 319 | 7.358e-07 | 2.977e-05 |
116 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 7 | 323 | 7.998e-07 | 3.208e-05 |
117 | REGULATION OF MAPK CASCADE | 9 | 660 | 8.332e-07 | 3.314e-05 |
118 | IMMUNE EFFECTOR PROCESS | 8 | 486 | 9.338e-07 | 3.682e-05 |
119 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 6 | 207 | 1.003e-06 | 3.922e-05 |
120 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 13 | 1672 | 1.083e-06 | 4.198e-05 |
121 | IMMUNE SYSTEM PROCESS | 14 | 1984 | 1.131e-06 | 4.312e-05 |
122 | REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 6 | 211 | 1.121e-06 | 4.312e-05 |
123 | REGULATION OF IMMUNE SYSTEM PROCESS | 12 | 1403 | 1.203e-06 | 4.55e-05 |
124 | GLYCEROLIPID METABOLIC PROCESS | 7 | 356 | 1.531e-06 | 5.744e-05 |
125 | PHOSPHOLIPID METABOLIC PROCESS | 7 | 364 | 1.774e-06 | 6.553e-05 |
126 | BLOOD VESSEL MORPHOGENESIS | 7 | 364 | 1.774e-06 | 6.553e-05 |
127 | NEGATIVE REGULATION OF CELL COMMUNICATION | 11 | 1192 | 1.844e-06 | 6.755e-05 |
128 | TOR SIGNALING | 3 | 16 | 2.259e-06 | 8.21e-05 |
129 | REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 3 | 17 | 2.739e-06 | 9.881e-05 |
130 | AUTOPHAGY | 7 | 394 | 2.998e-06 | 0.0001073 |
131 | POSITIVE REGULATION OF CATABOLIC PROCESS | 7 | 395 | 3.048e-06 | 0.0001083 |
132 | REGULATION OF NEURON DEATH | 6 | 252 | 3.139e-06 | 0.0001107 |
133 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 5 | 142 | 3.4e-06 | 0.0001189 |
134 | CELLULAR RESPONSE TO OXYGEN LEVELS | 5 | 143 | 3.519e-06 | 0.0001222 |
135 | IMMUNE SYSTEM DEVELOPMENT | 8 | 582 | 3.578e-06 | 0.0001233 |
136 | LEUKOCYTE MIGRATION | 6 | 259 | 3.676e-06 | 0.0001258 |
137 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 68 | 4.642e-06 | 0.0001577 |
138 | POSITIVE REGULATION OF CELL PROLIFERATION | 9 | 814 | 4.687e-06 | 0.000158 |
139 | CELL CYCLE | 11 | 1316 | 4.823e-06 | 0.0001615 |
140 | RESPONSE TO ACTIVITY | 4 | 69 | 4.922e-06 | 0.0001636 |
141 | ACTIVATION OF IMMUNE RESPONSE | 7 | 427 | 5.089e-06 | 0.0001679 |
142 | POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 3 | 21 | 5.334e-06 | 0.0001748 |
143 | RESPONSE TO PURINE CONTAINING COMPOUND | 5 | 158 | 5.732e-06 | 0.0001865 |
144 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 7 | 437 | 5.922e-06 | 0.0001914 |
145 | CELL CYCLE PROCESS | 10 | 1081 | 6.036e-06 | 0.0001937 |
146 | PEPTIDYL AMINO ACID MODIFICATION | 9 | 841 | 6.11e-06 | 0.0001947 |
147 | RESPONSE TO EXTRACELLULAR STIMULUS | 7 | 441 | 6.286e-06 | 0.000199 |
148 | POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 5 | 162 | 6.476e-06 | 0.0002036 |
149 | POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 4 | 75 | 6.872e-06 | 0.0002146 |
150 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 7 | 448 | 6.967e-06 | 0.0002161 |
151 | ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 450 | 7.173e-06 | 0.000221 |
152 | LEUKOCYTE DIFFERENTIATION | 6 | 292 | 7.313e-06 | 0.0002239 |
153 | LYMPHOCYTE COSTIMULATION | 4 | 78 | 8.037e-06 | 0.0002444 |
154 | CHEMICAL HOMEOSTASIS | 9 | 874 | 8.341e-06 | 0.000252 |
155 | ERBB SIGNALING PATHWAY | 4 | 79 | 8.456e-06 | 0.0002534 |
156 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 9 | 876 | 8.496e-06 | 0.0002534 |
157 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 5 | 172 | 8.667e-06 | 0.0002569 |
158 | INSULIN RECEPTOR SIGNALING PATHWAY | 4 | 80 | 8.891e-06 | 0.0002618 |
159 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 10 | 1152 | 1.058e-05 | 0.0003096 |
160 | POSITIVE REGULATION OF GENE EXPRESSION | 12 | 1733 | 1.088e-05 | 0.0003165 |
161 | REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 3 | 27 | 1.165e-05 | 0.0003367 |
162 | CELLULAR LIPID METABOLIC PROCESS | 9 | 913 | 1.185e-05 | 0.0003404 |
163 | REGULATION OF CELLULAR RESPONSE TO STRESS | 8 | 691 | 1.258e-05 | 0.0003591 |
164 | REGULATION OF NEUROBLAST PROLIFERATION | 3 | 28 | 1.304e-05 | 0.0003698 |
165 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 9 | 926 | 1.327e-05 | 0.0003743 |
166 | REGULATION OF RESPONSE TO STRESS | 11 | 1468 | 1.371e-05 | 0.0003843 |
167 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 9 | 957 | 1.727e-05 | 0.0004811 |
168 | FC GAMMA RECEPTOR SIGNALING PATHWAY | 4 | 95 | 1.759e-05 | 0.0004871 |
169 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 3 | 31 | 1.783e-05 | 0.0004908 |
170 | LYMPHOCYTE ACTIVATION | 6 | 342 | 1.795e-05 | 0.0004912 |
171 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 98 | 1.989e-05 | 0.0005411 |
172 | FC RECEPTOR SIGNALING PATHWAY | 5 | 206 | 2.073e-05 | 0.0005574 |
173 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 4 | 99 | 2.07e-05 | 0.0005574 |
174 | LYMPHOCYTE DIFFERENTIATION | 5 | 209 | 2.222e-05 | 0.0005941 |
175 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 5 | 213 | 2.433e-05 | 0.000647 |
176 | CELL DEATH | 9 | 1001 | 2.468e-05 | 0.0006524 |
177 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 8 | 767 | 2.67e-05 | 0.0007019 |
178 | TUBE DEVELOPMENT | 7 | 552 | 2.688e-05 | 0.0007028 |
179 | REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 37 | 3.061e-05 | 0.0007912 |
180 | POSITIVE REGULATION OF IMMUNE RESPONSE | 7 | 563 | 3.05e-05 | 0.0007912 |
181 | REGULATED EXOCYTOSIS | 5 | 224 | 3.097e-05 | 0.0007962 |
182 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 5 | 229 | 3.442e-05 | 0.0008752 |
183 | SINGLE ORGANISM BEHAVIOR | 6 | 384 | 3.441e-05 | 0.0008752 |
184 | PROTEIN HETEROOLIGOMERIZATION | 4 | 113 | 3.484e-05 | 0.0008809 |
185 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 8 | 801 | 3.64e-05 | 0.0009154 |
186 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 3 | 40 | 3.879e-05 | 0.0009651 |
187 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 3 | 40 | 3.879e-05 | 0.0009651 |
188 | POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 3 | 42 | 4.497e-05 | 0.001101 |
189 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 3 | 42 | 4.497e-05 | 0.001101 |
190 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 10 | 1360 | 4.457e-05 | 0.001101 |
191 | POSITIVE REGULATION OF CELL CELL ADHESION | 5 | 243 | 4.567e-05 | 0.001107 |
192 | REGULATION OF PROTEIN KINASE B SIGNALING | 4 | 121 | 4.554e-05 | 0.001107 |
193 | RESPONSE TO ELECTRICAL STIMULUS | 3 | 43 | 4.828e-05 | 0.001159 |
194 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 4 | 123 | 4.855e-05 | 0.001159 |
195 | T CELL DIFFERENTIATION | 4 | 123 | 4.855e-05 | 0.001159 |
196 | REGULATION OF CELL DEVELOPMENT | 8 | 836 | 4.931e-05 | 0.001171 |
197 | LEUKOCYTE ACTIVATION | 6 | 414 | 5.233e-05 | 0.001236 |
198 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 10 | 1395 | 5.534e-05 | 0.001301 |
199 | LEUKOCYTE CELL CELL ADHESION | 5 | 255 | 5.742e-05 | 0.001343 |
200 | NEUROGENESIS | 10 | 1402 | 5.775e-05 | 0.001343 |
201 | NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 4 | 131 | 6.208e-05 | 0.001437 |
202 | REGULATION OF GROWTH | 7 | 633 | 6.416e-05 | 0.001471 |
203 | POSITIVE REGULATION OF CELL DIVISION | 4 | 132 | 6.395e-05 | 0.001471 |
204 | POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS | 4 | 133 | 6.585e-05 | 0.001477 |
205 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 4 | 133 | 6.585e-05 | 0.001477 |
206 | REGULATION OF LIPID KINASE ACTIVITY | 3 | 48 | 6.729e-05 | 0.001477 |
207 | POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 4 | 133 | 6.585e-05 | 0.001477 |
208 | POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 3 | 48 | 6.729e-05 | 0.001477 |
209 | RESPONSE TO DRUG | 6 | 431 | 6.54e-05 | 0.001477 |
210 | CELL DEVELOPMENT | 10 | 1426 | 6.668e-05 | 0.001477 |
211 | POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS | 3 | 48 | 6.729e-05 | 0.001477 |
212 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 5 | 263 | 6.647e-05 | 0.001477 |
213 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 5 | 264 | 6.767e-05 | 0.001478 |
214 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 9 | 1142 | 6.93e-05 | 0.001507 |
215 | LIPID METABOLIC PROCESS | 9 | 1158 | 7.718e-05 | 0.00167 |
216 | REGULATION OF CELL DIVISION | 5 | 272 | 7.792e-05 | 0.001679 |
217 | REGULATION OF ORGANELLE ORGANIZATION | 9 | 1178 | 8.808e-05 | 0.001889 |
218 | RESPONSE TO LIGHT STIMULUS | 5 | 280 | 8.933e-05 | 0.001907 |
219 | NEURON PROJECTION EXTENSION | 3 | 53 | 9.063e-05 | 0.001926 |
220 | SINGLE ORGANISM CELL ADHESION | 6 | 459 | 9.254e-05 | 0.001957 |
221 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 3 | 54 | 9.585e-05 | 0.00201 |
222 | REGULATION OF VESICLE MEDIATED TRANSPORT | 6 | 462 | 9.591e-05 | 0.00201 |
223 | REGULATION OF CELL DIFFERENTIATION | 10 | 1492 | 9.76e-05 | 0.002037 |
224 | TAXIS | 6 | 464 | 9.822e-05 | 0.00204 |
225 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 3 | 55 | 0.0001013 | 0.002094 |
226 | REGULATION OF DEVELOPMENTAL GROWTH | 5 | 289 | 0.0001037 | 0.002134 |
227 | RESPONSE TO STARVATION | 4 | 154 | 0.0001163 | 0.002383 |
228 | VESICLE MEDIATED TRANSPORT | 9 | 1239 | 0.0001297 | 0.002648 |
229 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 3 | 60 | 0.0001314 | 0.002669 |
230 | REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 3 | 61 | 0.000138 | 0.002768 |
231 | REGULATION OF HOMOTYPIC CELL CELL ADHESION | 5 | 307 | 0.0001376 | 0.002768 |
232 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 3 | 61 | 0.000138 | 0.002768 |
233 | EXOCYTOSIS | 5 | 310 | 0.000144 | 0.002875 |
234 | POSITIVE REGULATION OF CELL ACTIVATION | 5 | 311 | 0.0001462 | 0.002906 |
235 | RESPONSE TO OSMOTIC STRESS | 3 | 63 | 0.0001519 | 0.003008 |
236 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 8 | 983 | 0.0001531 | 0.003019 |
237 | REGULATION OF EPITHELIAL CELL MIGRATION | 4 | 166 | 0.0001552 | 0.003047 |
238 | RESPONSE TO CARBOHYDRATE | 4 | 168 | 0.0001625 | 0.003164 |
239 | REGULATION OF AXONOGENESIS | 4 | 168 | 0.0001625 | 0.003164 |
240 | REGULATION OF CELLULAR LOCALIZATION | 9 | 1277 | 0.0001633 | 0.003166 |
241 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 6 | 513 | 0.0001699 | 0.003281 |
242 | REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 4 | 171 | 0.000174 | 0.00329 |
243 | FATTY ACID HOMEOSTASIS | 2 | 12 | 0.0001725 | 0.00329 |
244 | REGULATION OF RESPONSE TO NUTRIENT LEVELS | 4 | 171 | 0.000174 | 0.00329 |
245 | NEGATIVE REGULATION OF NEURON DEATH | 4 | 171 | 0.000174 | 0.00329 |
246 | POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 2 | 12 | 0.0001725 | 0.00329 |
247 | BEHAVIOR | 6 | 516 | 0.0001754 | 0.003304 |
248 | REGULATION OF CELL SIZE | 4 | 172 | 0.0001779 | 0.003338 |
249 | CELLULAR RESPONSE TO DRUG | 3 | 67 | 0.0001824 | 0.003409 |
250 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 7 | 750 | 0.0001846 | 0.003436 |
251 | POSITIVE REGULATION OF AXONOGENESIS | 3 | 69 | 0.0001991 | 0.003691 |
252 | INDUCTION OF POSITIVE CHEMOTAXIS | 2 | 13 | 0.0002036 | 0.003759 |
253 | REGULATION OF CELLULAR COMPONENT SIZE | 5 | 337 | 0.0002123 | 0.003905 |
254 | HOMEOSTATIC PROCESS | 9 | 1337 | 0.000231 | 0.004231 |
255 | SINGLE ORGANISM BIOSYNTHETIC PROCESS | 9 | 1340 | 0.0002349 | 0.004247 |
256 | CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 2 | 14 | 0.0002373 | 0.004247 |
257 | REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 2 | 14 | 0.0002373 | 0.004247 |
258 | INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 14 | 0.0002373 | 0.004247 |
259 | T CELL MIGRATION | 2 | 14 | 0.0002373 | 0.004247 |
260 | REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 3 | 73 | 0.0002353 | 0.004247 |
261 | CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 3 | 74 | 0.0002449 | 0.004367 |
262 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 4 | 188 | 0.00025 | 0.00444 |
263 | GRANULOCYTE MIGRATION | 3 | 75 | 0.0002549 | 0.004492 |
264 | CELLULAR GLUCOSE HOMEOSTASIS | 3 | 75 | 0.0002549 | 0.004492 |
265 | PHAGOCYTOSIS | 4 | 190 | 0.0002603 | 0.00457 |
266 | NUCLEAR TRANSPORT | 5 | 355 | 0.0002701 | 0.004721 |
267 | PROTEIN AUTOPHOSPHORYLATION | 4 | 192 | 0.0002709 | 0.004721 |
268 | RESPIRATORY BURST | 2 | 15 | 0.0002735 | 0.004744 |
269 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 3 | 77 | 0.0002755 | 0.004744 |
270 | DEVELOPMENTAL CELL GROWTH | 3 | 77 | 0.0002755 | 0.004744 |
271 | DEVELOPMENTAL MATURATION | 4 | 193 | 0.0002763 | 0.004744 |
272 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 5 | 360 | 0.0002881 | 0.004929 |
273 | RESPONSE TO ALCOHOL | 5 | 362 | 0.0002956 | 0.005037 |
274 | RESPIRATORY SYSTEM DEVELOPMENT | 4 | 197 | 0.0002987 | 0.005073 |
275 | NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 3 | 80 | 0.0003084 | 0.005202 |
276 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 6 | 573 | 0.0003086 | 0.005202 |
277 | CIRCULATORY SYSTEM PROCESS | 5 | 366 | 0.0003109 | 0.005222 |
278 | POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 16 | 0.0003123 | 0.005227 |
279 | POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING | 3 | 81 | 0.0003199 | 0.005315 |
280 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 5 | 368 | 0.0003188 | 0.005315 |
281 | REGULATION OF TRANSLATIONAL INITIATION | 3 | 82 | 0.0003316 | 0.005492 |
282 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 4 | 203 | 0.0003348 | 0.005524 |
283 | REGULATION OF ENERGY HOMEOSTASIS | 2 | 17 | 0.0003535 | 0.005764 |
284 | SECRETION | 6 | 588 | 0.0003543 | 0.005764 |
285 | MAMMARY GLAND ALVEOLUS DEVELOPMENT | 2 | 17 | 0.0003535 | 0.005764 |
286 | MAMMARY GLAND LOBULE DEVELOPMENT | 2 | 17 | 0.0003535 | 0.005764 |
287 | REGULATION OF CELL CELL ADHESION | 5 | 380 | 0.0003693 | 0.005988 |
288 | CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 2 | 18 | 0.0003973 | 0.006375 |
289 | RESPONSE TO CAFFEINE | 2 | 18 | 0.0003973 | 0.006375 |
290 | MAST CELL MEDIATED IMMUNITY | 2 | 18 | 0.0003973 | 0.006375 |
291 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 6 | 602 | 0.0004016 | 0.006422 |
292 | REGULATION OF STEM CELL PROLIFERATION | 3 | 88 | 0.0004082 | 0.006482 |
293 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 3 | 88 | 0.0004082 | 0.006482 |
294 | REGULATION OF IMMUNE RESPONSE | 7 | 858 | 0.0004191 | 0.006633 |
295 | CELL CELL ADHESION | 6 | 608 | 0.0004234 | 0.006678 |
296 | GLAND DEVELOPMENT | 5 | 395 | 0.0004409 | 0.00693 |
297 | CELLULAR RESPONSE TO LIGHT STIMULUS | 3 | 91 | 0.0004504 | 0.007056 |
298 | REGULATION OF PROTEIN STABILITY | 4 | 221 | 0.0004617 | 0.007209 |
299 | MORPHOGENESIS OF AN EPITHELIUM | 5 | 400 | 0.0004669 | 0.007265 |
300 | NEURON DIFFERENTIATION | 7 | 874 | 0.0004684 | 0.007265 |
301 | NEURON PROJECTION MORPHOGENESIS | 5 | 402 | 0.0004776 | 0.007383 |
302 | EMBRYONIC HEMOPOIESIS | 2 | 20 | 0.0004924 | 0.007536 |
303 | CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 2 | 20 | 0.0004924 | 0.007536 |
304 | RESPONSE TO MUSCLE ACTIVITY | 2 | 20 | 0.0004924 | 0.007536 |
305 | ORGANOPHOSPHATE METABOLIC PROCESS | 7 | 885 | 0.0005049 | 0.007703 |
306 | GROWTH | 5 | 410 | 0.0005224 | 0.007944 |
307 | CARDIOCYTE DIFFERENTIATION | 3 | 96 | 0.0005267 | 0.007983 |
308 | EMBRYO DEVELOPMENT | 7 | 894 | 0.0005365 | 0.008082 |
309 | MAST CELL ACTIVATION | 2 | 21 | 0.0005437 | 0.008082 |
310 | POSITIVE T CELL SELECTION | 2 | 21 | 0.0005437 | 0.008082 |
311 | RESPONSE TO RADIATION | 5 | 413 | 0.00054 | 0.008082 |
312 | POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 2 | 21 | 0.0005437 | 0.008082 |
313 | NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 2 | 21 | 0.0005437 | 0.008082 |
314 | REGULATION OF VASCULATURE DEVELOPMENT | 4 | 233 | 0.0005634 | 0.008348 |
315 | MYELOID LEUKOCYTE MIGRATION | 3 | 99 | 0.0005763 | 0.008512 |
316 | POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 2 | 22 | 0.0005974 | 0.008659 |
317 | POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 2 | 22 | 0.0005974 | 0.008659 |
318 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 3 | 100 | 0.0005934 | 0.008659 |
319 | REGULATION OF CELLULAR RESPIRATION | 2 | 22 | 0.0005974 | 0.008659 |
320 | TISSUE DEVELOPMENT | 9 | 1518 | 0.0005918 | 0.008659 |
321 | ERK1 AND ERK2 CASCADE | 2 | 22 | 0.0005974 | 0.008659 |
322 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 7 | 917 | 0.0006243 | 0.009022 |
323 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 3 | 103 | 0.0006468 | 0.009318 |
324 | LYSOSOME LOCALIZATION | 2 | 23 | 0.0006536 | 0.009329 |
325 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 2 | 23 | 0.0006536 | 0.009329 |
326 | POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 2 | 23 | 0.0006536 | 0.009329 |
327 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 3 | 104 | 0.0006653 | 0.009467 |
328 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 5 | 437 | 0.0006973 | 0.009892 |
329 | POSITIVE REGULATION OF TRANSPORT | 7 | 936 | 0.0007053 | 0.009975 |
330 | CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 2 | 24 | 0.0007123 | 0.009983 |
331 | REGULATION OF POSITIVE CHEMOTAXIS | 2 | 24 | 0.0007123 | 0.009983 |
332 | POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 2 | 24 | 0.0007123 | 0.009983 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | KINASE ACTIVITY | 22 | 842 | 5.182e-23 | 4.814e-20 |
2 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 22 | 992 | 1.834e-21 | 8.519e-19 |
3 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 16 | 445 | 2.279e-18 | 7.057e-16 |
4 | PROTEIN KINASE ACTIVITY | 17 | 640 | 2.274e-17 | 5.282e-15 |
5 | ADENYL NUCLEOTIDE BINDING | 18 | 1514 | 2.09e-12 | 3.884e-10 |
6 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 70 | 1.879e-11 | 2.909e-09 |
7 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 43 | 7.283e-11 | 8.457e-09 |
8 | RIBONUCLEOTIDE BINDING | 18 | 1860 | 6.633e-11 | 8.457e-09 |
9 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 6 | 51 | 2.132e-10 | 2.2e-08 |
10 | PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY | 4 | 16 | 1.102e-08 | 1.024e-06 |
11 | KINASE REGULATOR ACTIVITY | 7 | 186 | 1.871e-08 | 1.58e-06 |
12 | KINASE BINDING | 9 | 606 | 4.082e-07 | 3.16e-05 |
13 | INSULIN RECEPTOR SUBSTRATE BINDING | 3 | 11 | 6.692e-07 | 4.782e-05 |
14 | ENZYME BINDING | 13 | 1737 | 1.669e-06 | 0.0001107 |
15 | ENZYME REGULATOR ACTIVITY | 10 | 959 | 2.07e-06 | 0.0001282 |
16 | KINASE ACTIVATOR ACTIVITY | 4 | 62 | 3.202e-06 | 0.0001859 |
17 | MOLECULAR FUNCTION REGULATOR | 11 | 1353 | 6.298e-06 | 0.0003442 |
18 | INSULIN RECEPTOR BINDING | 3 | 32 | 1.965e-05 | 0.001014 |
19 | PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 3 | 39 | 3.592e-05 | 0.001756 |
20 | ENZYME ACTIVATOR ACTIVITY | 6 | 471 | 0.0001066 | 0.004953 |
21 | GROWTH FACTOR ACTIVITY | 4 | 160 | 0.0001347 | 0.00596 |
22 | PHOSPHATASE BINDING | 4 | 162 | 0.0001413 | 0.005967 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 7 | 20 | 1.286e-15 | 7.511e-13 |
2 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 11 | 237 | 7.889e-14 | 2.304e-11 |
3 | EXTRINSIC COMPONENT OF MEMBRANE | 8 | 252 | 6.012e-09 | 1.17e-06 |
4 | TRANSFERASE COMPLEX | 11 | 703 | 8.943e-09 | 1.306e-06 |
5 | CATALYTIC COMPLEX | 11 | 1038 | 4.703e-07 | 5.493e-05 |
6 | PROTEIN KINASE COMPLEX | 4 | 90 | 1.42e-05 | 0.001382 |
7 | PLATELET ALPHA GRANULE LUMEN | 3 | 55 | 0.0001013 | 0.008449 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04150_mTOR_signaling_pathway | 33 | 52 | 7.926e-92 | 1.427e-89 | |
2 | hsa04151_PI3K_AKT_signaling_pathway | 23 | 351 | 1.59e-33 | 1.431e-31 | |
3 | hsa04910_Insulin_signaling_pathway | 18 | 138 | 3.785e-31 | 2.271e-29 | |
4 | hsa04012_ErbB_signaling_pathway | 13 | 87 | 4.178e-23 | 1.504e-21 | |
5 | hsa04914_Progesterone.mediated_oocyte_maturation | 13 | 87 | 4.178e-23 | 1.504e-21 | |
6 | hsa04510_Focal_adhesion | 15 | 200 | 5.203e-22 | 1.561e-20 | |
7 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 10 | 42 | 4.678e-20 | 1.203e-18 | |
8 | hsa04722_Neurotrophin_signaling_pathway | 12 | 127 | 8.004e-19 | 1.801e-17 | |
9 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 11 | 95 | 2.713e-18 | 5.426e-17 | |
10 | hsa04370_VEGF_signaling_pathway | 10 | 76 | 2.928e-17 | 5.271e-16 | |
11 | hsa04662_B_cell_receptor_signaling_pathway | 9 | 75 | 3.202e-15 | 5.24e-14 | |
12 | hsa04973_Carbohydrate_digestion_and_absorption | 8 | 44 | 3.729e-15 | 5.593e-14 | |
13 | hsa04664_Fc_epsilon_RI_signaling_pathway | 9 | 79 | 5.225e-15 | 7.234e-14 | |
14 | hsa04620_Toll.like_receptor_signaling_pathway | 9 | 102 | 5.671e-14 | 7.292e-13 | |
15 | hsa04014_Ras_signaling_pathway | 11 | 236 | 7.531e-14 | 9.037e-13 | |
16 | hsa04660_T_cell_receptor_signaling_pathway | 9 | 108 | 9.622e-14 | 1.082e-12 | |
17 | hsa04062_Chemokine_signaling_pathway | 10 | 189 | 3.427e-13 | 3.629e-12 | |
18 | hsa04380_Osteoclast_differentiation | 9 | 128 | 4.589e-13 | 4.589e-12 | |
19 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 9 | 136 | 7.987e-13 | 7.567e-12 | |
20 | hsa04210_Apoptosis | 8 | 89 | 1.413e-12 | 1.272e-11 | |
21 | hsa04070_Phosphatidylinositol_signaling_system | 7 | 78 | 4.103e-11 | 3.517e-10 | |
22 | hsa04810_Regulation_of_actin_cytoskeleton | 9 | 214 | 4.795e-11 | 3.923e-10 | |
23 | hsa04630_Jak.STAT_signaling_pathway | 8 | 155 | 1.278e-10 | 1e-09 | |
24 | hsa04670_Leukocyte_transendothelial_migration | 7 | 117 | 7.367e-10 | 5.525e-09 | |
25 | hsa04140_Regulation_of_autophagy | 4 | 34 | 2.75e-07 | 1.98e-06 | |
26 | hsa00562_Inositol_phosphate_metabolism | 4 | 57 | 2.281e-06 | 1.579e-05 | |
27 | hsa04920_Adipocytokine_signaling_pathway | 4 | 68 | 4.642e-06 | 3.095e-05 | |
28 | hsa04720_Long.term_potentiation | 4 | 70 | 5.214e-06 | 3.352e-05 | |
29 | hsa04114_Oocyte_meiosis | 4 | 114 | 3.606e-05 | 0.0002238 | |
30 | hsa04010_MAPK_signaling_pathway | 5 | 268 | 7.266e-05 | 0.000436 | |
31 | hsa04730_Long.term_depression | 3 | 70 | 0.0002078 | 0.001206 | |
32 | hsa04350_TGF.beta_signaling_pathway | 3 | 85 | 0.0003686 | 0.002074 | |
33 | hsa04270_Vascular_smooth_muscle_contraction | 2 | 116 | 0.01566 | 0.08543 | |
34 | hsa03013_RNA_transport | 2 | 152 | 0.02597 | 0.1375 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | HAND2-AS1 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-629-5p;hsa-miR-940 | 15 | IGF1 | Sponge network | -7.871 | 0 | -4.485 | 0.00149 | 0.653 |
2 | EMX2OS | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-452-5p;hsa-miR-486-5p;hsa-miR-629-5p;hsa-miR-940 | 14 | IGF1 | Sponge network | -6.205 | 0.00015 | -4.485 | 0.00149 | 0.631 |
3 | RP11-389C8.2 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p | 10 | IGF1 | Sponge network | -3.089 | 2.0E-5 | -4.485 | 0.00149 | 0.575 |
4 | MAGI2-AS3 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 | 16 | IGF1 | Sponge network | -4.563 | 0 | -4.485 | 0.00149 | 0.572 |
5 | RP11-887P2.5 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-27a-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-940 | 11 | IGF1 | Sponge network | -9.865 | 1.0E-5 | -4.485 | 0.00149 | 0.567 |
6 | AC003090.1 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-576-5p | 11 | IGF1 | Sponge network | -7.817 | 0.00161 | -4.485 | 0.00149 | 0.561 |
7 | MIR497HG | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-940 | 13 | IGF1 | Sponge network | -6.146 | 0.00024 | -4.485 | 0.00149 | 0.518 |
8 | ADAMTS9-AS1 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 | 14 | IGF1 | Sponge network | -8.573 | 0.00012 | -4.485 | 0.00149 | 0.499 |
9 | WT1-AS | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 | 16 | IGF1 | Sponge network | -6.875 | 2.0E-5 | -4.485 | 0.00149 | 0.493 |
10 | MIR143HG | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 | 14 | IGF1 | Sponge network | -6.51 | 0 | -4.485 | 0.00149 | 0.49 |
11 | DNM3OS | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-940 | 14 | IGF1 | Sponge network | -3.933 | 0.00059 | -4.485 | 0.00149 | 0.483 |
12 | RP11-166D19.1 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-576-5p | 12 | IGF1 | Sponge network | -4.209 | 2.0E-5 | -4.485 | 0.00149 | 0.477 |
13 | ZNF667-AS1 | hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-452-5p;hsa-miR-629-5p | 10 | IGF1 | Sponge network | -4.019 | 0.00137 | -4.485 | 0.00149 | 0.383 |
14 | FAM66C | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-940 | 10 | IGF1 | Sponge network | -2.927 | 0.00012 | -4.485 | 0.00149 | 0.38 |
15 | ACTA2-AS1 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-576-5p | 12 | IGF1 | Sponge network | -6.142 | 0.00223 | -4.485 | 0.00149 | 0.332 |